Clinical Trial Economics, Policy & Industry Trends

Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered

Posted on By digi

Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered The landscape of clinical trials is continuously evolving, and with it comes a host of questions from investors, board members, and C-suite executives regarding outsourcing trends and consolidation in the industry. This comprehensive guide provides…

Read More “Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered” »

Outsourcing Trends & Consolidation

Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks

Posted on By digi

Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks Introduction to Outsourcing Trends in Clinical Trials In recent years, the outsourcing landscape of clinical trials has undergone significant changes that reflect the evolving demands of the biopharmaceutical industry. As companies increasingly seek to enhance…

Read More “Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks” »

Outsourcing Trends & Consolidation

Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation

Posted on By digi

Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation Introduction to Clinical Trial Outsourcing Trends In contemporary clinical research, outsourcing has become a pervasive practice among pharmaceutical and biopharmaceutical companies. The dynamics of clinical trials are evolving, necessitating a comprehensive…

Read More “Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation” »

Outsourcing Trends & Consolidation

KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation

Posted on By digi

KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation The clinical research landscape is continuously evolving, particularly in the context of oncology clinical research. As trial methodologies adapt to various external pressures, biopharma companies are increasingly adopting advanced analytics tools to enhance their operational…

Read More “KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation” »

Outsourcing Trends & Consolidation

Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations

Posted on By digi

Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations The clinical research landscape is rapidly evolving. As professionals in clinical operations, regulatory affairs, and medical affairs comprehend the significance of adopting emerging technologies in clinical trials, understanding technology adoption curves becomes crucial. This article explores how AI, decentralized trials (DCT),…

Read More “Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations” »

Technology Adoption Curves (AI, DCT, eSource)

High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins

Posted on By digi

High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins Understanding Patient Enrollment in Clinical Trials: The Foundation for Effective Technology Adoption Patient enrollment in clinical trials serves as a critical element of the drug development process,…

Read More “High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins” »

Technology Adoption Curves (AI, DCT, eSource)

Technology Adoption Curves (AI, DCT, eSource) in Practice: Benchmarks, Case Studies and Playbooks

Posted on By digi

Technology Adoption Curves (AI, DCT, eSource) in Practice: Benchmarks, Case Studies and Playbooks Technology Adoption Curves (AI, DCT, eSource) in Practice: Benchmarks, Case Studies and Playbooks Understanding Technology Adoption in Clinical Trials In the ever-evolving landscape of clinical research, the integration of innovative technologies is essential for the successful execution of clinical trials. Understanding the…

Read More “Technology Adoption Curves (AI, DCT, eSource) in Practice: Benchmarks, Case Studies and Playbooks” »

Technology Adoption Curves (AI, DCT, eSource)

How to Model Technology Adoption Curves (AI, DCT, eSource) for Global Study Portfolios

Posted on By digi

How to Model Technology Adoption Curves (AI, DCT, eSource) for Global Study Portfolios How to Model Technology Adoption Curves (AI, DCT, eSource) for Global Study Portfolios The evolution of technology within the clinical trial landscape has necessitated a systematic approach to understanding technology adoption curves. This article provides a step-by-step tutorial for clinical operations, regulatory…

Read More “How to Model Technology Adoption Curves (AI, DCT, eSource) for Global Study Portfolios” »

Technology Adoption Curves (AI, DCT, eSource)

Technology Adoption Curves (AI, DCT, eSource): What Clinical Leaders Need to Know Now

Posted on By digi

Technology Adoption Curves (AI, DCT, eSource): What Clinical Leaders Need to Know Now In the dynamic landscape of clinical research and trials, technology adoption is critical. As clinical leaders navigate the complexities of clinical trial design and execution, challenges and opportunities emerge. With a focus on Artificial Intelligence (AI), Decentralized Trials (DCT), and eSource technologies,…

Read More “Technology Adoption Curves (AI, DCT, eSource): What Clinical Leaders Need to Know Now” »

Technology Adoption Curves (AI, DCT, eSource)

Governance Models and Cross-Functional Ownership for Technology Adoption Curves (AI, DCT, eSource)

Posted on By digi

Governance Models and Cross-Functional Ownership for Technology Adoption Curves (AI, DCT, eSource) The implementation of innovative technologies in clinical trials, such as Artificial Intelligence (AI), Decentralized Trials (DCT), and eSource solutions, is rapidly evolving the landscape of clinical research. This article will provide a comprehensive, step-by-step guide on governance models and the importance of cross-functional…

Read More “Governance Models and Cross-Functional Ownership for Technology Adoption Curves (AI, DCT, eSource)” »

Technology Adoption Curves (AI, DCT, eSource)